Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 21;102(14):1083-95.
doi: 10.1093/jnci/djq238. Epub 2010 Jul 15.

Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study

Debra L Friedman  1 , John Whitton, Wendy Leisenring, Ann C Mertens, Sue Hammond, Marilyn Stovall, Sarah S Donaldson, Anna T Meadows, Leslie L Robison, Joseph P Neglia
Affiliations

Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study

Debra L Friedman et al. J Natl Cancer Inst. .

Abstract

Background: The occurrence of subsequent neoplasms has direct impact on the quantity and quality of life in cancer survivors. We have expanded our analysis of these events in the Childhood Cancer Survivor Study (CCSS) to better understand the occurrence of these events as the survivor population ages.

Methods: The incidence of and risk for subsequent neoplasms occurring 5 years or more after the childhood cancer diagnosis were determined among 14,359 5-year survivors in the CCSS who were treated from 1970 through 1986 and who were at a median age of 30 years (range = 5-56 years) for this analysis. At 30 years after childhood cancer diagnosis, we calculated cumulative incidence at 30 years of subsequent neoplasms and calculated standardized incidence ratios (SIRs), excess absolute risks (EARs) for invasive second malignant neoplasms, and relative risks for subsequent neoplasms by use of multivariable Poisson regression.

Results: Among 14,359 5-year survivors, 1402 subsequently developed 2703 neoplasms. Cumulative incidence at 30 years after the childhood cancer diagnosis was 20.5% (95% confidence interval [CI] = 19.1% to 21.8%) for all subsequent neoplasms, 7.9% (95% CI = 7.2% to 8.5%) for second malignant neoplasms (excluding nonmelanoma skin cancer), 9.1% (95% CI = 8.1% to 10.1%) for nonmelanoma skin cancer, and 3.1% (95% CI = 2.5% to 3.8%) for meningioma. Excess risk was evident for all primary diagnoses (EAR = 2.6 per 1000 person-years, 95% CI = 2.4 to 2.9 per 1000 person-years; SIR = 6.0, 95% CI = 5.5 to 6.4), with the highest being for Hodgkin lymphoma (SIR = 8.7, 95% CI = 7.7 to 9.8) and Ewing sarcoma (SIR = 8.5, 95% CI = 6.2 to 11.7). In the Poisson multivariable analysis, female sex, older age at diagnosis, earlier treatment era, diagnosis of Hodgkin lymphoma, and treatment with radiation therapy were associated with increased risk of subsequent neoplasm.

Conclusions: As childhood cancer survivors progress through adulthood, risk of subsequent neoplasms increases. Patients surviving Hodgkin lymphoma are at greatest risk. There is no evidence of risk reduction with increasing duration of follow-up.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative incidence of second neoplasms (SNs) at 30 years after initial cancer diagnosis. A) All SNs. Cumulative incidence of any SN, nonmelanoma skin cancer (NMSC), second malignant neoplasm (SMN), and meningioma is shown. B) All SNs stratified by radiation therapy (RT) treatment or no RT.
Figure 2
Figure 2
Cumulative incidence of second neoplasms (SNs) at 30 years after initial cancer diagnosis by childhood cancer diagnosis. Cumulative incidence of Hodgkin lymphoma (Hodgkins), non-Hodgkin lymphoma (NHL), neuroblastoma (NBL), central nervous system malignancies (all CNS), medulloblastoma or primitive neuroectodermal tumor (medullo/PNET), astrocytoma, Wilms tumor, all bone cancers, osteosarcoma (osteo), Ewing sarcoma (Ewings), and soft tissue sarcoma (STS) are shown.
See this image and copyright information in PMC

Comment in

References

    1. Ries LA, Eisner MP, Kosary CL, et al. SEER. In: Krapcho M, Neyman N, Aminou R, Waidron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK, editors. Cancer Statistics Review 1975–2003. Bethesda, MD: National Cancer Institute; http://seer.cancer.gov/csr/1975_2007. Accessed July 8, 2010.
    1. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21(23):4386–4394. - PubMed
    1. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93(8):618–629. - PubMed
    1. Garwicz S, Anderson H, Olsen JH, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer. 2000;88(4):672–678. - PubMed
    1. Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24(3):476–483. - PubMed

Publication types

MeSH terms